Rafarma Pharmaceuticals Inc RAFA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RAFA is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.06–0.07
- 52-Week Range
- $0.04–0.43
- Bid/Ask
- $0.06 / $0.07
- Market Cap
- $5.00 Mil
- Volume/Avg
- 24,483 / 34,598
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rafarma Pharmaceuticals Inc is engaged in pharmaceuticals and has several subsidiaries specializing in developing and producing medical equipment, as well as supplying equipment for hospitals and clinics from Germany, China, Slovakia, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.rafarma.si
Comparables
Valuation
|
Metric
|
RAFA
|
LFCR
|
ANIP
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 13.29 |
Price/Book Value | — | — | 2.94 |
Price/Sales | — | — | 2.31 |
Price/Cash Flow | — | — | 12.04 |
Price/Earnings
RAFA
LFCR
ANIP
Financial Strength
|
Metric
|
RAFA
|
LFCR
|
ANIP
|
|---|---|---|---|
Quick Ratio | — | 1.22 | 3.00 |
Current Ratio | — | 2.39 | 3.95 |
Interest Coverage | — | −2.63 | 2.81 |
Quick Ratio
RAFA
LFCR
ANIP
Profitability
|
Metric
|
RAFA
|
LFCR
|
ANIP
|
|---|---|---|---|
Return on Assets (Normalized) | — | −8.68% | 5.86% |
Return on Equity (Normalized) | — | −39.95% | 12.46% |
Return on Invested Capital (Normalized) | — | −4.61% | 9.81% |
Return on Assets
RAFA
LFCR
ANIP
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Vpxrqhjc | Jtjpx | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Ggdrrkhfb | Rrhqdct | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Sljxmkc | Lph | $41.4 Bil | |||
| Viatris Inc
VTRS
| Jrhmbmyb | Cmlg | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Gdnxmcgwp | Yfxrq | $13.7 Bil | |||
| Catalent Inc
CTLT
| Dtdyklbzc | Kfhtmzf | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Gwrjsbpr | Djlpx | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Qzyxsfkm | Mrtvc | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Qbpccvmw | Wffp | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Hcgxjrbtl | Kptfk | $2.7 Bil |